TG Therapeutics TGTX Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's net gains (losses) on investments?
- TG Therapeutics (TGTX) reported net gains (losses) on investments of $1.53M in Q1 2026.
- How has TG Therapeutics's net gains (losses) on investments changed year-over-year?
- TG Therapeutics's net gains (losses) on investments increased by 1575.0% year-over-year, from -$104K to $1.53M.
- What does net gains (losses) on investments mean?
- The non-cash profit or loss from changes in the market value of investment holdings.
- How do you interpret net gains (losses) on investments?
- High volatility here can obscure the underlying operational performance of the company.
- How does net gains (losses) on investments compare across companies?
- Common for companies with significant treasury management or strategic equity investments.